| Detected | Trial | Change |
|---|---|---|
| 2026-07-07 | NCT07007793 A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary… |
date change Primary completion moved earlier: 2028-02-18 -> 2027-08-13 |
| 2026-07-07 | NCT07007793 A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary… |
date change Completion pushed: 2028-02-18 -> 2028-08-14 |
| 2026-07-03 | NCT07081646 A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With… |
Primary endpoint(s) modified |
| 2026-07-03 | NCT07343960 A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in… |
date change Primary completion pushed: 2026-07-31 -> 2026-11-11 |
| 2026-07-03 | NCT07343960 A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in… |
date change Completion pushed: 2026-07-31 -> 2026-11-11 |
| 2026-07-03 | NCT05775159 Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-03 | NCT05775159 Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents… |
Trial sites reduced: 60 -> 46 locations |
| 2026-07-03 | NCT07000357 A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of… |
Trial sites expanded: 1333 -> 1365 locations |
| 2026-07-03 | NCT07201558 Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE… |
Trial sites expanded: 19 -> 33 locations |
| 2026-07-03 | NCT06008093 A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With… |
date change Primary completion moved earlier: 2026-12-08 -> 2026-10-23 |
| 2026-07-03 | NCT06008093 A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With… |
date change Completion pushed: 2027-12-23 -> 2028-02-28 |
| 2026-07-03 | NCT07024706 Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for… |
Recruitment opened |
| 2026-07-03 | NCT07024706 Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for… |
Trial sites expanded: 29 -> 36 locations |
| 2026-07-03 | NCT07024706 Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for… |
date change Completion pushed: 2029-05-15 -> 2033-03-23 |
| 2026-07-03 | NCT03330847 To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus… |
date change Completion pushed: 2026-09-04 -> 2026-10-09 |
| 2026-07-03 | NCT04504825 A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb… |
Primary endpoint(s) modified |
| 2026-07-03 | NCT05460273 A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer… |
date change Completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-07-03 | NCT07017179 This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-03 | NCT07017179 This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With… |
Enrollment reduced: 871 -> 14 participants |
| 2026-07-02 | NCT07024823 A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of… |
date change Primary completion pushed: 2026-06-18 -> 2026-12-25 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-06 | NCT07685600 Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy… | Phase 1 | Not Yet Recruiting |
| 2026-07-02 | NCT07681596 A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With… | Phase 1/2 | Not Yet Recruiting |
| 2026-06-29 | NCT07674121 PROLONG (PRostateOLaparibONcombinationGcc) Study | Not Yet Recruiting | |
| 2026-06-25 | NCT07667803 A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With… | Phase 3 | Not Yet Recruiting |
| 2026-06-24 | NCT07664553 A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With… | Phase 3 | Not Yet Recruiting |
| 2026-06-23 | NCT07662044 A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in… | Phase 3 | Not Yet Recruiting |
| 2026-06-23 | NCT07662109 A Phase III Study to Investigate the Efficacy and Safety of the Combination of… | Phase 3 | Not Yet Recruiting |
| 2026-06-23 | NCT07662135 A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With… | Phase 3 | Not Yet Recruiting |
| 2026-06-23 | NCT07662213 A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes… | Phase 3 | Not Yet Recruiting |
| 2026-06-23 | NCT07663409 The DEBATE Study "DEvelopment of Endotype-based Biomarkers for the Monitoring of Greek… | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07306949 | Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association… | Transthyretin-type Cardiac Amyloidosis | Recruiting |
| NCT07221838 | A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia… | Generalized Myasthenia Gravis | Recruiting |
| NCT06531798 | Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian… | Moderate to Severe COPD | Recruiting |
| NCT07308574 | Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS | aHUS | Recruiting |
| NCT07279935 | Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After… | Non-small Cell Lung Cancer | Recruiting |
| NCT06651970 | Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL… | Chronic Lymphocytic Leukaemia | Recruiting |
| NCT06594068 | Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in… | Systemic Lupus Erythematosus | Recruiting |
| NCT07073950 | A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate… | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT07357597 | An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd)… | Stomatitis | Not Yet Recruiting |
| NCT06610526 | A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease | Chronic Kidney Disease | Active, Not Recruiting |
| NCT06422689 | Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on… | Asthma | Active, Not Recruiting |
| NCT05457257 | Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With… | Metastatic Castration-resistant Prostate Cancer | Active, Not Recruiting |
| NCT03953300 | Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics | Asthma | Active, Not Recruiting |
| Phase 3 | |||
| NCT07218809 | AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low… | Epithelial Ovarian Cancer | Recruiting |
| NCT07024563 | Study of Ravulizumab in Pediatric Participants With Primary IgAN | IgAN | Recruiting |
| NCT06607627 | PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+… | Generalized Myasthenia Gravis | Recruiting |
| NCT06350097 | Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab… | Non-small Cell Lung Cancer | Recruiting |
| NCT07205822 | A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0… | Breast Cancer | Recruiting |
| NCT06750289 | Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as… | Eosinophilic Asthma | Recruiting |
| NCT06417814 | A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib… | Metastatic Non-small Cell Lung Cancer | Recruiting |
| NCT06868277 | A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line… | Carcinoma, Non-Small Cell Lung | Recruiting |
| NCT06471257 | A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic… | Asthma | Recruiting |
| NCT06677060 | Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in… | Heart Failure | Recruiting |
| NCT06455449 | A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as… | Polymyositis, Dermatomyositis | Recruiting |
| NCT05692180 | A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled… | Asthma | Recruiting |